SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
Press Releases
February 26, 2025

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026Joint R&D project between SK and CEPI includes up

bradford

The Bradford Era

Local & Social